COLL (STOCKS)
Collegium Pharmaceutical, Inc. Common Stock
$45.140000
-1.610000 (-3.44%)
Prev close: $46.750000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Vikram Karnani
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,425.97M
- Employees
- 357
- P/E (TTM)
- 29.10
- P/B (TTM)
- 5.38
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
7
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$2.25 | $2.08 | +0.1651 | +7.92% |
|
Jun 2025 (Q2)
|
$1.68 | $1.65 | +0.0310 | +1.88% |
|
Mar 2025 (Q1)
|
$1.49 | $1.46 | +0.0286 | +1.96% |
|
Dec 2024 (Q4)
|
$1.77 | $1.57 | +0.2015 | +12.85% |
Financial Statements
| Assets | $1.61B |
| Current Assets | $613.87M |
| Inventory | $38.05M |
| Other Current Assets | $575.82M |
| Noncurrent Assets | $993.46M |
| Fixed Assets | $12.25M |
| Intangible Assets | $724.98M |
| Other Non-current Assets | $256.23M |
| Liabilities | $1.33B |
| Current Liabilities | $452.93M |
| Accounts Payable | $7.65M |
| Wages | $4.10M |
| Other Current Liabilities | $441.18M |
| Noncurrent Liabilities | $879.59M |
| Equity | $274.81M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $274.81M |
| Liabilities And Equity | $1.61B |